Literature DB >> 25830001

Quality of diabetes care at outpatient clinic, sultan qaboos university hospital.

Sawsan Al-Sinani1, Ali Al-Mamari2, Nicolas Woodhouse2, Omaiyma Al-Shafie2, Fatima Amar2, Mohammed Al-Shafaee3, Mohammed Hassan4, Riad Bayoumi1.   

Abstract

OBJECTIVE: To assess the clinical care of type 2 diabetes mellitus (T2D) patients at Sultan Qaboos University Hospital (SQUH), a countrywide tertiary referral center in Muscat, Oman. .
METHODS: We performed a retrospective, observational, cross-sectional study using a total of 673 Omani T2D patients from the Diabetes and Family Medicine Clinics at SQUH. We collected patient data from June 2010 to February 2012 from the Hospital Information System (HIS). Patients had to be Omani, aged more than 18 years old, and have T2D with active follow-up and at least three visits within one year to be included in the study. Ninety-three percent of the patients (n=622) were on oral hypoglycemic drugs and/or insulin, and 70% were on statins. Patients' anthropometric data, biochemical investigations, blood pressure, and duration of diabetes were recorded from the HIS. .
RESULTS: Using the recommended standards and guidelines of medical care in diabetes (American Diabetes Association and the American National Cholesterol Education Program III NCDP NIII standards), we observed that 22% of the patients achieved a HbA1C goal of <7%, 47% achieved blood pressure goal of <140/80mm Hg, 48% achieved serum low density lipoprotein cholesterol goal of <2.6mmol/L, 67% achieved serum triglycerides goal of <1.7 mmol/L, 59% of males and 43% of females achieved high density lipoprotein cholesterol goals (males>1.0; females >1.3mmol/L). Almost 60% of the patients had urinary microalbumin/creatinine ratio within the normal range. .
CONCLUSIONS: The clinical outcomes of the care that T2D patients get at SQUH were lower than those reported in Europe and North America. However, it is similar to those reported in other countries in the Arabian Gulf.

Entities:  

Keywords:  Oman; Outpatient Clinics, Hospital; Type 2 Diabetes Mellitus

Year:  2015        PMID: 25830001      PMCID: PMC4371458          DOI: 10.5001/omj.2015.09

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  35 in total

1.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

2.  Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

Authors:  Amanda I Adler; Richard J Stevens; Sue E Manley; Rudy W Bilous; Carole A Cull; Rury R Holman
Journal:  Kidney Int       Date:  2003-01       Impact factor: 10.612

Review 3.  Systematic review on urine albumin testing for early detection of diabetic complications.

Authors:  D J Newman; M B Mattock; A B S Dawnay; S Kerry; A McGuire; M Yaqoob; G A Hitman; C Hawke
Journal:  Health Technol Assess       Date:  2005-08       Impact factor: 4.014

4.  Diabetes guidelines: easier to preach than to practise?

Authors:  Wendy Bryant; Jerry R Greenfield; Donald J Chisholm; Lesley V Campbell
Journal:  Med J Aust       Date:  2006-09-18       Impact factor: 7.738

5.  Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India.

Authors:  A Varghese; R Deepa; M Rema; V Mohan
Journal:  Postgrad Med J       Date:  2001-06       Impact factor: 2.401

6.  Control of Hypertension among Type II Diabetics.

Authors:  Kawther El-Shafie; Sayed Rizvi
Journal:  Oman Med J       Date:  2010-01

Review 7.  Management of diabetic dyslipidemia.

Authors:  Maria Del Pilar Solano; Ronald B Goldberg
Journal:  Endocrinol Metab Clin North Am       Date:  2005-03       Impact factor: 4.741

Review 8.  Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes.

Authors:  K Khunti; R Gadsby; C Millett; A Majeed; M Davies
Journal:  Diabet Med       Date:  2007-10-29       Impact factor: 4.359

9.  Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico.

Authors:  Ricardo Pérez-Cuevas; Svetlana V Doubova; Magdalena Suarez-Ortega; Michael Law; Aakanksha H Pande; Jorge Escobedo; Francisco Espinosa-Larrañaga; Dennis Ross-Degnan; Anita K Wagner
Journal:  BMC Med Inform Decis Mak       Date:  2012-06-06       Impact factor: 2.796

10.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

View more
  2 in total

1.  Metabolic Disturbances in Obese Pregnant Residents of an Industrial Region (The Urals, Russia).

Authors:  Kovalchuk Liudmila Akhmetovna; Tarkhanova Alla Eduardovna; Chernaya Liudmila Vladimirovna; Mikshevich Nikolay Vladislavovich
Journal:  Oman Med J       Date:  2016-05

Review 2.  Diabetes in the Middle East: Government Health Care Policies and Strategies that Address the Growing Diabetes Prevalence in the Middle East.

Authors:  Noor Al Busaidi; Prakash Shanmugam; Deepa Manoharan
Journal:  Curr Diab Rep       Date:  2019-02-04       Impact factor: 4.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.